Pearl River Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,605
| Closed | -$1.64M | – | 436 |
|
|
2024
Q1 | $1.64M | Buy |
+7,605
| New | +$1.64M | 0.26% | 129 |
|
|
2023
Q4 | – | Sell |
-4,098
| Closed | -$1.05M | – | 483 |
|
|
2023
Q3 | $1.05M | Buy |
4,098
+1,376
| +51% | +$354K | 0.17% | 209 |
|
|
2023
Q2 | $775K | Sell |
2,722
-1,378
| -34% | -$393K | 0.13% | 246 |
|
|
2023
Q1 | $1.14M | Sell |
4,100
-6,454
| -61% | -$1.79M | 0.18% | 176 |
|
|
2022
Q4 | $2.92M | Buy |
10,554
+1,512
| +17% | +$419K | 0.5% | 42 |
|
|
2022
Q3 | $2.41M | Sell |
9,042
-4,954
| -35% | -$1.32M | 0.45% | 58 |
|
|
2022
Q2 | $2.85M | Buy |
13,996
+1,422
| +11% | +$290K | 0.67% | 31 |
|
|
2022
Q1 | $2.65M | Buy |
+12,574
| New | +$2.65M | 0.73% | 29 |
|
|
2021
Q4 | – | Sell |
-3,714
| Closed | -$1.05M | – | 423 |
|
|
2021
Q3 | $1.05M | Buy |
3,714
+1,262
| +51% | +$357K | 0.29% | 119 |
|
|
2021
Q2 | $849K | Sell |
2,452
-2,836
| -54% | -$982K | 0.23% | 144 |
|
|
2021
Q1 | $1.48M | Buy |
+5,288
| New | +$1.48M | 0.47% | 51 |
|
|
2020
Q3 | – | Sell |
-9,509
| Closed | -$2.54M | – | 359 |
|
|
2020
Q2 | $2.54M | Buy |
+9,509
| New | +$2.54M | 1.26% | 7 |
|
|
2020
Q1 | – | Sell |
-4,449
| Closed | -$1.32M | – | 517 |
|
|
2019
Q4 | $1.32M | Buy |
+4,449
| New | +$1.32M | 0.49% | 26 |
|